01.02.2017
- In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...
23.01.2017
- Eli Lilly is paying around $960 million to acquire biopharma CoLucid, boosting the US drugmaker’s portfolio for migraine pain management and adding a late-stage candidate with a...
13.01.2017
- American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...
07.10.2016
- German drugmaker Boehringer Ingelheim is selling the pet vaccines portfolio of its US subsidiary Vetmedica to Eli Lilly’s animal health subsidiary Elanco for $885 million to allay...
20.09.2016
- French drugmaker Sanofi has filed a patent infringement suit in the United States District Court for the District of Delaware charging US pharmaceutical producer Merck with...
01.08.2016
- Long-time Eli Lilly chairman and CEO, John C. Lechleiter, has announced plans to retire in December of this year after 30 years with the US drugmaker. Succeeding the 62-year-old...
14.04.2016
- Bayer is still committed to expanding its animal health business, but would consider selling it if suitable takeover targets remain elusive, newly named CEO Werner Baumann has told...
11.04.2016
- Eli Lilly and AstraZeneca are moving into Phase 3 of their Amaranth study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor that could be a potential treatment...
